NCT05063461View on ClinicalTrials.gov

Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 25, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

March 1, 2023

Conditions
General Anesthesia
Interventions
DEVICE

Tetanic stimulation

For each participant, record the first concentration that ANI≥50 after the tetanic stimuli, as the sufficient concentration.

PROCEDURE

Skin incision

Infuse the sufficient concentration for at least 5min of the steady-state period, then surgical stimulus is applied. The surgical stimulus is defined as the first skin incision to establish pneumoperitoneum.

Trial Locations (1)

100020

Beijing Chao Yang Hospital, Beijing

All Listed Sponsors
lead

Beijing Chao Yang Hospital

OTHER

NCT05063461 - Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane | Biotech Hunter | Biotech Hunter